266 related articles for article (PubMed ID: 17363301)
1. Ikaros DNA-binding proteins as integral components of B cell developmental-stage-specific regulatory circuits.
Thompson EC; Cobb BS; Sabbattini P; Meixlsperger S; Parelho V; Liberg D; Taylor B; Dillon N; Georgopoulos K; Jumaa H; Smale ST; Fisher AG; Merkenschlager M
Immunity; 2007 Mar; 26(3):335-44. PubMed ID: 17363301
[TBL] [Abstract][Full Text] [Related]
2. Aiolos: an ungrateful member of the Ikaros family.
Kioussis D
Immunity; 2007 Mar; 26(3):275-7. PubMed ID: 17376390
[TBL] [Abstract][Full Text] [Related]
3. The pre-B-cell receptor induces silencing of VpreB and lambda5 transcription.
Parker MJ; Licence S; Erlandsson L; Galler GR; Chakalova L; Osborne CS; Morgan G; Fraser P; Jumaa H; Winkler TH; Skok J; Mårtensson IL
EMBO J; 2005 Nov; 24(22):3895-905. PubMed ID: 16281060
[TBL] [Abstract][Full Text] [Related]
4. EBF and E47 collaborate to induce expression of the endogenous immunoglobulin surrogate light chain genes.
Sigvardsson M; O'Riordan M; Grosschedl R
Immunity; 1997 Jul; 7(1):25-36. PubMed ID: 9252117
[TBL] [Abstract][Full Text] [Related]
5. Binding of Ikaros to the lambda5 promoter silences transcription through a mechanism that does not require heterochromatin formation.
Sabbattini P; Lundgren M; Georgiou A; Chow C; Warnes G; Dillon N
EMBO J; 2001 Jun; 20(11):2812-22. PubMed ID: 11387214
[TBL] [Abstract][Full Text] [Related]
6. The lambda5-VpreB1 locus--a model system for studying gene regulation during early B cell development.
Sabbattini P; Dillon N
Semin Immunol; 2005 Apr; 17(2):121-7. PubMed ID: 15737573
[TBL] [Abstract][Full Text] [Related]
7. Ikaros and Aiolos inhibit pre-B-cell proliferation by directly suppressing c-Myc expression.
Ma S; Pathak S; Mandal M; Trinh L; Clark MR; Lu R
Mol Cell Biol; 2010 Sep; 30(17):4149-58. PubMed ID: 20566697
[TBL] [Abstract][Full Text] [Related]
8. Surrogate-light-chain silencing is not critical for the limitation of pre-B cell expansion but is for the termination of constitutive signaling.
van Loo PF; Dingjan GM; Maas A; Hendriks RW
Immunity; 2007 Sep; 27(3):468-80. PubMed ID: 17869135
[TBL] [Abstract][Full Text] [Related]
9. The unique region of surrogate light chain component lambda5 is a heavy chain-specific regulator of precursor B cell receptor signaling.
Guloglu FB; Bajor E; Smith BP; Roman CA
J Immunol; 2005 Jul; 175(1):358-66. PubMed ID: 15972669
[TBL] [Abstract][Full Text] [Related]
10. Integrated STAT3 and Ikaros Zinc Finger Transcription Factor Activities Regulate Bcl-6 Expression in CD4
Read KA; Powell MD; Baker CE; Sreekumar BK; Ringel-Scaia VM; Bachus H; Martin RE; Cooley ID; Allen IC; Ballesteros-Tato A; Oestreich KJ
J Immunol; 2017 Oct; 199(7):2377-2387. PubMed ID: 28848064
[TBL] [Abstract][Full Text] [Related]
11. Silencing and nuclear repositioning of the lambda5 gene locus at the pre-B cell stage requires Aiolos and OBF-1.
Karnowski A; Cao C; Matthias G; Carotta S; Corcoran LM; Martensson IL; Skok JA; Matthias P
PLoS One; 2008; 3(10):e3568. PubMed ID: 18974788
[TBL] [Abstract][Full Text] [Related]
12. Aiolos, a lymphoid restricted transcription factor that interacts with Ikaros to regulate lymphocyte differentiation.
Morgan B; Sun L; Avitahl N; Andrikopoulos K; Ikeda T; Gonzales E; Wu P; Neben S; Georgopoulos K
EMBO J; 1997 Apr; 16(8):2004-13. PubMed ID: 9155026
[TBL] [Abstract][Full Text] [Related]
13. Interferon regulatory factors 4 and 8 induce the expression of Ikaros and Aiolos to down-regulate pre-B-cell receptor and promote cell-cycle withdrawal in pre-B-cell development.
Ma S; Pathak S; Trinh L; Lu R
Blood; 2008 Feb; 111(3):1396-403. PubMed ID: 17971486
[TBL] [Abstract][Full Text] [Related]
14. Overlapping expression of early B-cell factor and basic helix-loop-helix proteins as a mechanism to dictate B-lineage-specific activity of the lambda5 promoter.
Sigvardsson M
Mol Cell Biol; 2000 May; 20(10):3640-54. PubMed ID: 10779354
[TBL] [Abstract][Full Text] [Related]
15. Early B cell factor binds to a site critical for lambda5 core enhancer activity.
Mårtensson A; Mårtensson IL
Eur J Immunol; 1997 Jan; 27(1):315-20. PubMed ID: 9022034
[TBL] [Abstract][Full Text] [Related]
16. Formation of an active tissue-specific chromatin domain initiated by epigenetic marking at the embryonic stem cell stage.
Szutorisz H; Canzonetta C; Georgiou A; Chow CM; Tora L; Dillon N
Mol Cell Biol; 2005 Mar; 25(5):1804-20. PubMed ID: 15713636
[TBL] [Abstract][Full Text] [Related]
17. Aiolos controls gene conversion and cell death in DT40 B cells.
Narvi E; Nera KP; Terho P; Mustonen L; Granberg J; Lassila O
Scand J Immunol; 2007 Jun; 65(6):503-13. PubMed ID: 17523942
[TBL] [Abstract][Full Text] [Related]
18. The human V-preB promoter is a target for coordinated activation by early B cell factor and E47.
Gisler R; Sigvardsson M
J Immunol; 2002 May; 168(10):5130-8. PubMed ID: 11994467
[TBL] [Abstract][Full Text] [Related]
19. A truncated heavy chain protein relieves the requirement for surrogate light chains in early B cell development.
Shaffer AL; Schlissel MS
J Immunol; 1997 Aug; 159(3):1265-75. PubMed ID: 9233622
[TBL] [Abstract][Full Text] [Related]
20. The 14.1 surrogate light chain promoter has lineage- and stage-restricted activity.
Donohoe ME; Blomberg BB
J Immunol; 1997 Feb; 158(4):1681-91. PubMed ID: 9029104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
